Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer

• Iori Motoo,
• Takayuki Ando,
• Takeru Hamashima,
• Shinya Kajiura,
• Miho Sakumura,
• Yuko Ueda,
• Aiko Murayama,
• Kohei Ogawa,
• Kenichiro Tsukada,
• Akira Ueda,
• Nobuhiro Suzuki,
• Naokatsu Nakada,
• Koji Nakashima,
• Ayumu Hosokawa,
• Ayumu Hosokawa,
• Ichiro Yasuda

Affiliations

Iori Motoo

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Takayuki Ando

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Takeru Hamashima

Department of Pathology, University of Toyama, Toyama, Japan

Shinya Kajiura

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Miho Sakumura

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Yuko Ueda

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Aiko Murayama

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Kohei Ogawa

Department of Gastroenterology, Toyama Prefectural Central Hospital, Toyama, Japan

Kenichiro Tsukada

Department of Gastroenterology, Kouseiren Takaoka Hospital, Takaoka, Japan

Akira Ueda

Department of Medical Oncology, Toyama Red Cross Hospital, Toyama, Japan

Nobuhiro Suzuki

Department of Gastroenterology, Jouetsu Sogo Hospital, Jouetsu, Japan

Naokatsu Nakada

Department of Gastroenterology, Itoigawa Sogo Hospital, Itoigawa, Japan

Koji Nakashima

Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan

Ayumu Hosokawa

Third Department of Internal Medicine, University of Toyama, Toyama, Japan

Ayumu Hosokawa

Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan

Ichiro Yasuda

Third Department of Internal Medicine, University of Toyama, Toyama, Japan